News
HyClone Laboratories, LLC (“HyClone”) filed a Motion to Quash in the U.S. District Court for the District of Utah, seeking to ...
Dr Reddys stock rose 5.5% in six sessions post-Q4 results, outperforming the BSE Healthcare index. Strong revenue growth, ...
Dr Sachin Almel, section head, medical oncology, P. D. Hinduja Hospital and Medical Research Centre, Mahim, added that ...
Science and society collaboration is essential for scientific progress, especially in the health and biomedical fields where basic researchers, clinicians and patients are involved, as shown by the ...
5d
Pharmaceutical Technology on MSNFDA biosimilar approvals set for record-breaking year amid US pricing reformsThere were also five new drugs referencing the ophthalmology drug Eylea (aflibercept) that gained FDA approval in 2024.
Early results from a clinical trial suggest that while denosumab does not directly reduce the proliferation of breast cancer ...
Patients with rheumatoid arthritis (RA) who switched from Enbrel (reference etanercept) to a biosimilar maintained remission, ...
Once prostate cancer no longer responds to hormonal therapy, the cancer is called castration-resistant. Find out which ...
Biocon Biologics Ltd (“BBL”) announced that the EMA’s Committee for Medicinal Products for Human Use (“CHMP”) had issued positive ...
Individuals taking steroid tablets for more than 3 months are over 6 times more likely to be diagnosed with adrenal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results